- Benign prostrate hyperplasia (BPH):
- 1 cap OD
Capsule: 0.5mg/0.4mg
- It should not be handled with pregnant women or women considering to get pregnant
- Effects of this medication are seen after 3-6 months
- Taken 30 min after meals
- Capsules are deformed/discoloured in high temperatures
Dutasteride: 5-alpha-reductase inhibitor. It inhibits conversion of testosterone to dihydrotestosterone (DHT) via inhibition of 5-alpha-reductase types 1 and 2
Tamsulosin: Alpha-adrenergic antagonist. It blocks alpha-1a adrenergic receptor in smooth muscle of prostate, decreasing bladder neck & urethral resistance
- Abnormal ejaculation
- Impotence
- Decreased libido
- Decreased ejaculate volume
- Decreased sperm count
- Hypersensitivity to class/components
- Pregnancy
- Avoid handling drug in pregnant or potentially pregnant individuals
- Avoid blood donation during treatment and for at least 6 months after discontinuing
- Ombitasvir
- Paritaprevir
- Ritonavir
- Dasabuvir
Drug Status
| Availability | Prescription only |
| Pregnancy | Category X |
| Breastfeeding | Not indicated in women |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| D-Tam | 0.5mg/0.4mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
| Dustam | 0.4mg/0.5mg | Capsule | 30’s | Dolopharma Healthcare | Dolopharma Healthcare |
| Duodart | 0.5mg/0.4mg | Capsule | 30’s | GSK Ltd | GSK Ltd |
| Tamdura | 0.5mg/0.4mg | Tablet | 30’s | Stallion Labs | Krishna Chemists |
| Tamsu-D | 0.5mg/0.4mg | Capsule | 30’s | Kausikh Therapeutics | Sai Pharma |